Ytterbium
Among its 7 stable isotopes, isotope 176 of Ytterbium is of major interest for radiopharmaceuticals as it is the precursor for Lutetium-177, b-emitter radio-isotope used in particular for targeted radiotherapy of prostate and neuroendocrines tumors. This type of therapy should grow considerably in the coming years. This application requires a high-level enrichment and a very high chemical purity.
The Solution
With its atomic vapor laser isotope separation process (AVLIS) based on the process jointly developed with French CEA for uranium enrichment, Orano Stable Isotopes will be able* to separate lanthanides isotopes and, in particular 176Yb, up to an enrichment grade over 99.5%.
Orano offers a solution for enrichment of Ytterbium based on a reliable and high-perfomance process.
Key Features
- Enrichment over 99.5% in 176Yb using AVLIS process at the Tricastin site, in France*
- Delivery under either metal or oxide form
(*) subject to prior approval by Orano’s Board of Management of set-up of the industrial-scale equipment
Your Benefits at a glance
- Enrichment and chemical form according to the client’s needs
- Very high chemical and isotopic purity
- Proven technology
- Reliable and thorough European supply chain and production
